BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29561855)

  • 1. Accumulation of mechanical forces in tumors is related to hyaluronan content and tissue stiffness.
    Voutouri C; Stylianopoulos T
    PLoS One; 2018; 13(3):e0193801. PubMed ID: 29561855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner.
    Papageorgis P; Polydorou C; Mpekris F; Voutouri C; Agathokleous E; Kapnissi-Christodoulou CP; Stylianopoulos T
    Sci Rep; 2017 Apr; 7():46140. PubMed ID: 28393881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronan-Derived Swelling of Solid Tumors, the Contribution of Collagen and Cancer Cells, and Implications for Cancer Therapy.
    Voutouri C; Polydorou C; Papageorgis P; Gkretsi V; Stylianopoulos T
    Neoplasia; 2016 Dec; 18(12):732-741. PubMed ID: 27886639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pirfenidone normalizes the tumor microenvironment to improve chemotherapy.
    Polydorou C; Mpekris F; Papageorgis P; Voutouri C; Stylianopoulos T
    Oncotarget; 2017 Apr; 8(15):24506-24517. PubMed ID: 28445938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hyaluronan on xenotransplanted breast cancer.
    Herrera-Gayol A; Jothy S
    Exp Mol Pathol; 2002 Jun; 72(3):179-85. PubMed ID: 12009781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sonic-hedgehog pathway inhibition normalizes desmoplastic tumor microenvironment to improve chemo- and nanotherapy.
    Mpekris F; Papageorgis P; Polydorou C; Voutouri C; Kalli M; Pirentis AP; Stylianopoulos T
    J Control Release; 2017 Sep; 261():105-112. PubMed ID: 28662901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the FGFR-STAT3 pathway in breast cancer cells induces a hyaluronan-rich microenvironment that licenses tumor formation.
    Bohrer LR; Chuntova P; Bade LK; Beadnell TC; Leon RP; Brady NJ; Ryu Y; Goldberg JE; Schmechel SC; Koopmeiners JS; McCarthy JB; Schwertfeger KL
    Cancer Res; 2014 Jan; 74(1):374-86. PubMed ID: 24197137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity.
    Panagi M; Voutouri C; Mpekris F; Papageorgis P; Martin MR; Martin JD; Demetriou P; Pierides C; Polydorou C; Stylianou A; Louca M; Koumas L; Costeas P; Kataoka K; Cabral H; Stylianopoulos T
    Theranostics; 2020; 10(4):1910-1922. PubMed ID: 32042344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of growth-induced, mechanical stress in solid tumors and spatial association with extracellular matrix content.
    Hadjigeorgiou AG; Stylianopoulos T
    Biomech Model Mechanobiol; 2023 Oct; 22(5):1625-1643. PubMed ID: 37129689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.
    Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS
    Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced chemotherapeutic efficacy of the low-dose doxorubicin in breast cancer via nanoparticle delivery system crosslinked hyaluronic acid.
    Wang Q; Zhong Y; Liu W; Wang Z; Gu L; Li X; Zheng J; Du H; Zhong Z; Xie F
    Drug Deliv; 2019 Dec; 26(1):12-22. PubMed ID: 30691317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2-Targeted PET Imaging and Therapy of Hyaluronan-Masked HER2-Overexpressing Breast Cancer.
    Pereira PMR; Ragupathi A; Shmuel S; Mandleywala K; Viola NT; Lewis JS
    Mol Pharm; 2020 Jan; 17(1):327-337. PubMed ID: 31804840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironment.
    Kultti A; Zhao C; Singha NC; Zimmerman S; Osgood RJ; Symons R; Jiang P; Li X; Thompson CB; Infante JR; Jacobetz MA; Tuveson DA; Frost GI; Shepard HM; Huang Z
    Biomed Res Int; 2014; 2014():817613. PubMed ID: 25147816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models.
    Thompson CB; Shepard HM; O'Connor PM; Kadhim S; Jiang P; Osgood RJ; Bookbinder LH; Li X; Sugarman BJ; Connor RJ; Nadjsombati S; Frost GI
    Mol Cancer Ther; 2010 Nov; 9(11):3052-64. PubMed ID: 20978165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimuli-Responsive Polysaccharide Enveloped Liposome for Targeting and Penetrating Delivery of survivin-shRNA into Breast Tumor.
    Chen H; Fan X; Zhao Y; Zhi D; Cui S; Zhang E; Lan H; Du J; Zhang Z; Zhang S; Zhen Y
    ACS Appl Mater Interfaces; 2020 May; 12(19):22074-22087. PubMed ID: 32083833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronidase-1 expression promotes lung metastasis in syngeneic mouse tumor models without affecting accumulation of small hyaluronan oligosaccharides in tumor interstitial fluid.
    Schmaus A; Sleeman JP
    Glycobiology; 2015 Mar; 25(3):258-68. PubMed ID: 25354852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors.
    Rizzardi AE; Vogel RI; Koopmeiners JS; Forster CL; Marston LO; Rosener NK; Akentieva N; Price MA; Metzger GJ; Warlick CA; Henriksen JC; Turley EA; McCarthy JB; Schmechel SC
    Cancer; 2014 Jun; 120(12):1800-9. PubMed ID: 24668563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human decellularized adipose tissue scaffold as a model for breast cancer cell growth and drug treatments.
    Dunne LW; Huang Z; Meng W; Fan X; Zhang N; Zhang Q; An Z
    Biomaterials; 2014 Jun; 35(18):4940-9. PubMed ID: 24661550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment.
    Koyama H; Kobayashi N; Harada M; Takeoka M; Kawai Y; Sano K; Fujimori M; Amano J; Ohhashi T; Kannagi R; Kimata K; Taniguchi S; Itano N
    Am J Pathol; 2008 Jan; 172(1):179-93. PubMed ID: 18079437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.